Patient A | |
Information on CoDe form | Patient died due to liver failure as a consequence of HCV infection |
Patient had clinical signs of liver failure in the 3 weeks prior to death | |
CD4 cell count prior to death 48 cells·mm−3 | |
HIV RNA no data | |
Autopsy not performed | |
Additional clinical information | |
TB | Pulmonary TB diagnosed 3 years earlier, bacteriologically confirmed, fully susceptible to anti-TB drugs |
Completed RHZE treatment, no TB recurrence reported | |
HIV | Known HIV positive for 13 years |
CD4 cell count at TB diagnosis 245 cells·mm−3 | |
HIV RNA 500 000 copies·mL−1 | |
No ART | |
CoDe review process | Immediate COD was coded as “liver failure due to HCV infection” |
Patient B | |
Information on CoDe form | Patient died due to dissemination of TB with multiorgan failure |
Condition had deteriorated during the last 1.5 months due to irregular treatment | |
Autopsy: macrofocal pulmonary TB with haematogenous dissemination; medium and small caverns with caseous necrosis in upper lung lobes bilateral, drained to bronchi; TB in kidneys, spleen, intra- and extrathoracic lymph nodes; tuberculous meningitis with brain oedema. Patient died due to brain oedema and multiorgan failure | |
Additional clinical information | |
TB | Disseminated MDR-TB diagnosed 14 months earlier |
Anti-TB treatment RHZ combined with amikacin and ethionamide, but poor adherence to treatment and several episodes of treatment interruptions | |
HIV | Known HIV-positive for 8 years |
ART initiated after TB diagnosis, but interrupted after 6 months at patient’s wish | |
CD4 cell count at TB diagnosis 78 cells·mm−3 and at time of death 255 cells·mm−3 | |
HIV RNA not measured | |
CoDe review process | Immediate COD was coded as “disseminated TB with TB meningitis” |
Patient C | |
Information on CoDe form | Patient died after progressive pulmonary failure over a month |
No signs of TB progression | |
Autopsy: signs of PCP | |
No evidence for active TB process | |
Additional clinical information | |
TB | Presumptive (without positive culture and thus no susceptibility tests available) pulmonary TB diagnosed 1.5 years earlier with involvement of intra- and extrathoracic lymph nodes |
Initial anti-TB treatment was RH with the addition of Z and amikacin 2 months later for a total treatment duration of 8 months | |
No recurrence of TB reported | |
HIV | Known HIV positive for 8 years |
CD4 cell count 5 months prior to TB diagnosis 410 cells·mm−3, at time of death 135 cells·mm−3 | |
HIV RNA not measured | |
Patient did not receive ART | |
PCP was not diagnosed while patient was alive and PCP treatment/prophylaxis not prescribed | |
CoDe review process | Immediate COD was coded as “non-TB AIDS defining condition, PCP” |
CoDe: Coding Causes of Death in HIV; TB: tuberculosis; HCV: hepatitis C virus; R: rifamycin; H: isoniazid; Z: pyrazinamide; E: ethambutol; COD: cause of death; ART: antiretroviral therapy; MDR: multidrug resistant; PCP: Pneumocystis jirovecii pneumonia.